131 related articles for article (PubMed ID: 35481356)
1. pH-sensitive nanoliposomes for passive and CXCR-4-mediated marine yessotoxin delivery for cancer therapy.
Vieira AM; Silvestre OF; Silva BF; Ferreira CJ; Lopes I; Gomes AC; Espiña B; Sárria MP
Nanomedicine (Lond); 2022 Apr; 17(10):717-739. PubMed ID: 35481356
[No Abstract] [Full Text] [Related]
2. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
3. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytosolic calcium levels of human lymphocytes by yessotoxin, a novel marine phycotoxin.
de la Rosa LA; Alfonso A; Vilariño N; Vieytes MR; Botana LM
Biochem Pharmacol; 2001 Apr; 61(7):827-33. PubMed ID: 11274968
[TBL] [Abstract][Full Text] [Related]
5. CXCR-7 receptor promotes SDF-1α-induced migration of bone marrow mesenchymal stem cells in the transient cerebral ischemia/reperfusion rat hippocampus.
Wang Y; Fu W; Zhang S; He X; Liu Z; Gao D; Xu T
Brain Res; 2014 Aug; 1575():78-86. PubMed ID: 24924806
[TBL] [Abstract][Full Text] [Related]
6. Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
Hattermann K; Holzenburg E; Hans F; Lucius R; Held-Feindt J; Mentlein R
Cell Tissue Res; 2014 Jul; 357(1):253-66. PubMed ID: 24770893
[TBL] [Abstract][Full Text] [Related]
7. [Exenatide promotes chemotactic migration of adipose-derived stem cells through SDF-1/CXCR-4/Rho GTPase pathway].
Ma Q; Yang JJ; Zhou H; Zhang Y; Chen YD
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(8):1034-40. PubMed ID: 27578569
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
Weekes CD; Song D; Arcaroli J; Wilson LA; Rubio-Viqueira B; Cusatis G; Garrett-Mayer E; Messersmith WA; Winn RA; Hidalgo M
Neoplasia; 2012 Aug; 14(8):690-701. PubMed ID: 22952422
[TBL] [Abstract][Full Text] [Related]
9. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway.
Xia R; Xu G; Huang Y; Sheng X; Xu X; Lu H
Life Sci; 2018 May; 201():111-120. PubMed ID: 29604270
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells.
Zhao XP; Huang YY; Huang Y; Lei P; Peng JL; Wu S; Wang M; Li WH; Zhu HF; Shen GX
Acta Pharmacol Sin; 2010 Mar; 31(3):347-54. PubMed ID: 20154716
[TBL] [Abstract][Full Text] [Related]
11. Histopathological studies on experimental marine toxin poisoning--5. The effects in mice of yessotoxin isolated from Patinopecten yessoensis and of a desulfated derivative.
Terao K; Ito E; Oarada M; Murata M; Yasumoto T
Toxicon; 1990; 28(9):1095-104. PubMed ID: 2260107
[TBL] [Abstract][Full Text] [Related]
12. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
Zhou W; Guo S; Liu M; Burow ME; Wang G
Curr Med Chem; 2019; 26(17):3026-3041. PubMed ID: 28875842
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of CXCR-4 and CCR-5 expression by interferon-gamma is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes.
Creery D; Weiss W; Lim WT; Aziz Z; Angel JB; Kumar A
Clin Exp Immunol; 2004 Jul; 137(1):156-65. PubMed ID: 15196257
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of yessotoxin and 45,46,47-trinoryessotoxin production by Protoceratium reticulatum collected in Japan.
Satake M; Ichimura T; Sekiguchi K; Yoshimatsu S; Oshima Y
Nat Toxins; 1999; 7(4):147-50. PubMed ID: 10797642
[TBL] [Abstract][Full Text] [Related]
16. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
[TBL] [Abstract][Full Text] [Related]
17. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
[TBL] [Abstract][Full Text] [Related]
18. [The mechanism of polypeptide derived from viral macrophage inflammatory protein II modulates SDF-1α/CXCR4-induced migration].
Yang QL; Ding YX; Chen CJ; Yang ZF; Gao YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):137-40. PubMed ID: 22304770
[TBL] [Abstract][Full Text] [Related]
19. Yessotoxin, a novel phycotoxin, activates phosphodiesterase activity. Effect of yessotoxin on cAMP levels in human lymphocytes.
Alfonso A; de la Rosa L; Vieytes MR; Yasumoto T; Botana LM
Biochem Pharmacol; 2003 Jan; 65(2):193-208. PubMed ID: 12504795
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells.
Hira VV; Verbovšek U; Breznik B; Srdič M; Novinec M; Kakar H; Wormer J; der Swaan BV; Lenarčič B; Juliano L; Mehta S; Van Noorden CJ; Lah TT
Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):594-603. PubMed ID: 28040478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
